Shanghai Sinotec (603121.SH): Termination of the issuance of shares to specific entities through simplified procedures in 2024.
Hua Pei Power (603121.SH) released an announcement that the company will hold its third board of directors meeting on September 25, 2024.
Shanghai Sinotec (603121.SH) announced that the company held the thirteenth meeting of the third board of directors and the tenth meeting of the third board of supervisors on September 25, 2024, and approved the proposal to terminate the issuance of shares to specific targets in 2024 through a simplified procedure.
Since the company first announced the issuance of shares to specific targets through a simplified procedure, the company's board of directors, management, and intermediary institutions have been actively promoting various work. In August 2024, the securities service agency hired for this issuance and listing application was suspended from engaging in securities services for six months. Considering the capital market environment, industry development, company strategy, and business situation, after careful study, the company decided to apply to Shanghai Stock Exchange to withdraw the application documents for the issuance of shares to specific targets through a simplified procedure.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025